VERILOID Drug Patent Profile
✉ Email this page to a colleague
When do Veriloid patents expire, and what generic alternatives are available?
Veriloid is a drug marketed by 3M and is included in one NDA.
The generic ingredient in VERILOID is alkavervir. Additional details are available on the alkavervir profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VERILOID?
- What are the global sales for VERILOID?
- What is Average Wholesale Price for VERILOID?
Summary for VERILOID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Patent Applications: | 181 |
| DailyMed Link: | VERILOID at DailyMed |
US Patents and Regulatory Information for VERILOID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | VERILOID | alkavervir | TABLET;ORAL | 007336-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| 3m | VERILOID | alkavervir | TABLET;ORAL | 007336-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
